glp 1 for overweight Efficacy of GLP-1 on weight loss, BMI, and waist circumference adults with or obesity GLP-1 Agonists In Obesity

Dosing Phases, Titration & Cycling Unlike short recovery peptides, semaglutide is not run in on/off cycles. The documented protocol is a single continuous escalation to a maintenance dose that is then held, because the metabolic effect depends on sustained receptor engagement weight tends to return when the drug is stopped

Choosing between these options should involve a discussion with your healthcare provider, considering your individual health circumstances, weight loss goals, and the potential side effects

The weight loss itself improves metabolic function, potentially reducing the dose required to maintain results

Salehi S, Naghib SM, Garshasbi HR, Ghorbanzadeh S, Zhang W

The LEADER trial was an international, randomised, double-blind, controlled cardiovascular outcomes trial (CVOT)